AI Article Synopsis
- Thyroid radiofrequency ablation (RFA) is a minimally invasive procedure used to treat benign thyroid nodules, offering an alternative to surgery or radioactive iodine with minimal risks and side effects.
- RFA shows a high efficacy, achieving a volume reduction of 67 to 75% in nodules within a year.
- The article also discusses thyroid artery embolization, another emerging technique for reducing nodule size in certain patients, particularly those unsuitable for surgery.
Article Abstract
Thyroid radiofrequency ablation (RFA) is a minimally invasive procedure that can be used to treat patients with benign thyroid nodules and is a good alternative to thyroidectomy or radioactive iodine. Thyroid RFA is commonly performed with local lidocaine or minimal/moderate sedation and has a minimal risk profile and few side effects. The efficacy of thyroid RFA has been well documented in the literature, with a volume reduction rate of 67 to 75% at 1 year. Another emerging technique for nodule size reduction is thyroid artery embolization which is a minimally invasive procedure that may be performed in patients with nodular goiters, particularly with substernal thyroid nodule extension, and who are either poor surgical candidates or do not want surgery. This article reviews thyroid RFA, focusing on the relevant preprocedural, procedural, and postprocedural imaging, as well as a discussion on the emerging role of thyroid artery embolization.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333111 | PMC |
| http://dx.doi.org/10.1055/s-0044-1788339 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!